Relationship between Adverse Events and AUC in Japanese Patients with Multiple Myeloma Receiving High-dose Melphalan
Author:
Affiliation:
1. Department of Pharmacy, Fukuoka University Chikushi Hospital
2. Division of Medical Oncology, Hematology and Infection Diseases, Department of Medicine, Fukuoka University Hospital
3. Department of Pharmacy, Fukuoka University Hospital
Publisher
Japanese Society of Pharmaceutical Health Care and Sciences
Subject
General Earth and Planetary Sciences,General Environmental Science
Link
https://www.jstage.jst.go.jp/article/jjphcs/46/7/46_396/_pdf
Reference15 articles.
1. 1）Martinez-Lopez J, Blade J, Mateos MV, Grande C, Alegre A, García-Laraña J, Sureda A, de la Rubia J, Conde E, Martinez R, de Arriba F, Viguria MC, Besalduch J, Cabrera R, Gonzalez-San Miguel JD, Guzman-Zamudio JL, Gomez del Castillo MC, Moraleda JM, García-Ruiz JC, San Miguel J, Lahuerta JJ, Grupo Español de MM, Programa para el Estudio de la Terapé utica en Hemopatía Maligna, Long-term prognostic significance of response in multiple myeloma after stem cell transplantation, Blood, 2011, 118, 529-534.
2. 2）Harousseau JL, Avet-Loiseau H, Attal M, Charbonnel C, Garban F, Hulin C, Michallet M, Facon T, Garderet L, Marit G, Ketterer N, Lamy T, Voillat L, Guilhot F, Doyen C, Mathiot C, Moreau P, Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials, J Clin Oncol, 2009, 27, 5720-5726.
3. 4）大平睦郎, 花田良二, 西平浩一, 松山孝治, 河 敬世, 河野嘉文, 岡村 純, L-PAMの小児がんに対する造血幹細胞移植時の前処置としての臨床試験, 日本小児血液学会雑誌, 2001, 15, 377-387.
4. 5）Natale JJ, Overview of the prevention and management of CINV, Am J Manag Care, 2018, 24, S391-S397.
5. 6）Riley P, Glenny AM, Worthington HV, Littlewood A, Clarkson JE, McCabe MG, Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy, Cochrane Database Syst Rev, 2015, 12, CD011552. doi: 10.1002/14651858.CD011552.pub2.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3